Clinical outcomes in BRAFV600-mutant metastatic melanoma with sequential treatment with immunotherapy and BRAF inhibitors or vice versa

Authors :: Lydia Gaba
Francisco Aya
Ana Arance
Aranzazu Fernandez
Iván Victoria
Estela Pineda
Source :: Journal of Clinical Oncology. 33:e20030-e20030
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: e20030 Background: Limited data exists on the sequencing of BRAF inhibitors (BRAFi) and immunotherapy (IT) in patients (pts) with BRAFV600-mutant metastatic melanoma (BRAFV600MM). The aim of this a...

Subjects :: Cancer Research
Metastatic melanoma
business.industry
medicine.medical_treatment
Mutant
Immunotherapy
Sequential treatment
Oncology
Immunology
Cancer research
medicine
In patient
business
neoplasms

Full Text Access

Tools